Detalhe da pesquisa
1.
Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group.
Br J Haematol
; 182(6): 859-869, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29984828
2.
A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.
Biol Blood Marrow Transplant
; 22(4): 698-704, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26785332
3.
Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy.
Blood
; 121(2): 278-85, 2013 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23149845
4.
Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1.
Br J Haematol
; 185(2): 374-377, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30117142
5.
A randomized controlled trial of graded exposure treatment (GET living) for adolescents with chronic pain.
Pain
; 165(1): 177-191, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37624900
6.
Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report.
Br J Haematol
; 162(5): 678-83, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23802659
7.
Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin's lymphoma: a phase II, non-randomized controlled trial.
J Immunother Cancer
; 10(5)2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35584865
8.
An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961.
Br J Haematol
; 148(4): 600-10, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19895612
9.
Graded exposure treatment for adolescents with chronic pain (GET Living): Protocol for a randomized controlled trial enhanced with single case experimental design.
Contemp Clin Trials Commun
; 16: 100448, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31650069
10.
The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia.
Bone Marrow Transplant
; 54(2): 226-235, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29899571
11.
A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group study.
Clin Cancer Res
; 13(18 Pt 2): 5652s-5660s, 2007 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17875803
12.
A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma.
Leukemia
; 35(10): 2994-2997, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33941850
13.
Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 study.
J Clin Oncol
; 30(4): 387-93, 2012 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22215753
14.
A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients.
Biol Blood Marrow Transplant
; 10(4): 246-58, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15077223